3DMed – Development and streamlined integration of 3D printing technologies to enable advanced medical treatment and its widespread application

Key information

  • EU funding: € 4.10 Million
  • Total budget: € 6.84 Million
  • Duration: 36 months (October 2018 – September 2021) 

Aim:

3DMed aims to improve affordability and large scale accessibility of medical treatment using 3D printed devices. Top universities and innovative companies in the Netherlands, Belgium, France and the UK will join forces in an unprecedented exercise to explore the full potential of the 3D printing technology for advanced medical care.

Expected results:

  • Streamlined care by integrating diagnosis, design and manufacturing of 3DP medical devices with post operatory evaluation into a validated and widely accessible software platform. This will enable reduction of lead times from 6-8 weeks currently to 6-8 days in by 2021 and to 24 hours in 2023.
  • Personalized medical devices (prostheses, implants, orthoses), designed using the images acquired for individual patients. Using 3D printing technology to achieve these customised devices will also trigger a drop in the cost of the device by as much as 90%. The cost of medical treatment will also decrease by 30%.
  • Complex shapes and miniaturized geometries for implants and surgical instruments, as well as functionalised devices to enhance treatment effectiveness and post-treatment recovery.

Project Partners

Observer Partners

More information about the project can be found here.

Contact EXO-L:

info(at)exo-l.com
+31 15 744 0155